U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
186031186031High Light and Low Light Dose PDT in GliomaCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: porfimer sodium|Procedure: adjuvant therapy|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00118222
186032186032Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell LymphomaActive, not recruitingNo Results AvailableLarge B Cell LymphomaBiological: rituximab|Drug: cyclophosphamide|Drug: doxorubicin|Drug: vincristine|Drug: prednisone|Drug: etoposide|Drug: filgrastim|Drug: pegfilgrastimhttps://ClinicalTrials.gov/show/NCT00118209
186033186033Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaCompletedNo Results AvailableLeukemia|Myelodysplastic SyndromesDrug: arsenic trioxide|Drug: azacitidinehttps://ClinicalTrials.gov/show/NCT00118196
186034186034Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNo Results AvailableAdenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Large Cell Lung Cancer|Malignant Pleural Effusion|Recurrent Non-small Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung CancerDrug: docetaxel|Biological: cetuximab|Drug: bortezomibhttps://ClinicalTrials.gov/show/NCT00118183
186035186035Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney FunctionCompletedNo Results AvailableExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult DiffDrug: sorafenib tosylate|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00118170
186036186036Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous TamoxifenCompletedHas ResultsEstrogen Receptor Positive|Male Breast Carcinoma|Progesterone Receptor Positive|Recurrent Breast Carcinoma|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast CancerOther: Laboratory Biomarker Analysis|Drug: Lapatinib Ditosylate|Drug: Tamoxifen Citratehttps://ClinicalTrials.gov/show/NCT00118157
186037186037Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung CancerCompletedHas ResultsAdenocarcinoma of the Lung|Bronchoalveolar Cell Lung Cancer|Non-small Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung CancerDrug: bortezomibhttps://ClinicalTrials.gov/show/NCT00118144
186038186038Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerTerminatedHas ResultsLung CancerDrug: cisplatin|Drug: docetaxelhttps://ClinicalTrials.gov/show/NCT00118131
186039186039S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal CancerWithdrawnNo Results AvailableColorectal Cancer|Metastatic CancerBiological: bevacizumab|Drug: capecitabine|Drug: oxaliplatin|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00118105
18604018604017-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone TherapyCompletedNo Results AvailableAdenocarcinoma of the Prostate|Recurrent Prostate Cancer|Stage IV Prostate CancerDrug: tanespimycin|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00118092
186041186041Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial NeoplasiaTerminatedNo Results AvailablePrecancerous/Nonmalignant Condition|Prostate CancerDietary Supplement: calcitriol|Procedure: observationhttps://ClinicalTrials.gov/show/NCT00118066
186042186042Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast CancerTerminatedHas ResultsBreast CancerBiological: herceptin|Drug: carboplatin|Drug: docetaxel|Procedure: conventional surgery|Procedure: radiation therapyhttps://ClinicalTrials.gov/show/NCT00118053
186043186043Genistein in Patients Who Are Undergoing Surgery for Bladder CancerCompletedNo Results AvailableBladder CancerDietary Supplement: genistein|Other: placebohttps://ClinicalTrials.gov/show/NCT00118040
186044186044A New Approach to Deliver Malaria Preventions to Pregnant Women at a Community Level in UgandaCompletedNo Results AvailableMalaria|Pregnancy|AnemiaDrug: sulphadoxine-pyrimethamine intermittent preventive treatmenthttps://ClinicalTrials.gov/show/NCT00118027
186045186045Sertraline and Habit Reversal in the Treatment of Patients With TrichotillomaniaCompletedNo Results AvailableImpulse Control DisordersDrug: Sertraline|Behavioral: Habit Reversal Traininghttps://ClinicalTrials.gov/show/NCT00118014
186046186046Psychotherapy of Generalized Anxiety DisorderCompletedNo Results AvailableAnxiety DisordersBehavioral: Worry exposure|Behavioral: Applied relaxationhttps://ClinicalTrials.gov/show/NCT00118001
18604718604717-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's LymphomaCompletedHas ResultsAnaplastic Large Cell Lymphoma|Recurrent Adult Hodgkin Lymphoma|Recurrent Mantle Cell LymphomaDrug: tanespimycinhttps://ClinicalTrials.gov/show/NCT00117988
186048186048Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's LymphomaCompletedNo Results AvailableLymphomaBiological: galiximab|Biological: rituximabhttps://ClinicalTrials.gov/show/NCT00117975
186049186049Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedHas ResultsLung CancerBiological: cetuximab|Drug: carboplatin|Drug: pemetrexed disodium|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00117962
186050186050Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486CompletedHas ResultsProstate CancerDrug: Degarelix|Drug: Degarelix|Drug: Degarelix|Drug: Degarelixhttps://ClinicalTrials.gov/show/NCT00117949
186051186051Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart DiseaseActive, not recruitingNo Results AvailableCoronary Disease|Coronary Heart Disease|Myocardial Ischemia|Coronary ArteriosclerosisDrug: Human Recombinant Fibroblast Growth Factor-1 (FGF 1-141)|Drug: Human Recombinant Fibroblast Growth Factor-1 (FGF 1-141)|Drug: Human Recombinant Fibroblast Growth Factor-1 (FGF 1-141)|Drug: Human Recombinant Fibroblast Growth Factor-1 (FGF1-141)https://ClinicalTrials.gov/show/NCT00117936
186052186052Study With a Topical Gel to Treat Common Warts in AdultsCompletedNo Results AvailableWartsDrug: Resiquimodhttps://ClinicalTrials.gov/show/NCT00117923
186053186053Treatment for Elderly Patients With High Risk Breast CancerCompletedNo Results AvailableBreast CancerDrug: pegfilgrastimhttps://ClinicalTrials.gov/show/NCT00117910
186054186054Treatment for Subjects With Non-Hodgkin's LymphomaCompletedNo Results AvailableNon-Hodgkin's LymphomaDrug: pegfilgrastim|Drug: Filgrastimhttps://ClinicalTrials.gov/show/NCT00117897
186055186055Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.TerminatedNo Results AvailablePapillomavirus InfectionsDrug: 851B|Drug: 851B|Drug: 851B|Drug: 851B|Drug: 851B|Drug: 851B|Drug: 851B|Drug: 851B|Drug: 851B|Drug: 851B|Drug: 851Bhttps://ClinicalTrials.gov/show/NCT00117884
186056186056Study With a Topical Gel to Treat Common Warts in AdultsCompletedNo Results AvailableWartsDrug: Resiquimodhttps://ClinicalTrials.gov/show/NCT00117871
186057186057Double Blind Trial of DC Polarization in FTDCompletedNo Results AvailableDementiaProcedure: Anodal DC polarization of left prefrontal cortexhttps://ClinicalTrials.gov/show/NCT00117858
186058186058Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell LeukemiaCompletedHas ResultsLeukemia, Adult T-CellBiological: Denileukin diftitox (Ontak)https://ClinicalTrials.gov/show/NCT00117845
186059186059Nasal Ocular Reflexes Contribute to Eye SymptomsCompletedNo Results AvailableRhinitis, Allergic, SeasonalDrug: Azelastine nasal sprayhttps://ClinicalTrials.gov/show/NCT00117832
186060186060A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's DiseaseCompletedNo Results AvailableParkinsonian SyndromeDrug: [123I]ß CIT and SPECT imaginghttps://ClinicalTrials.gov/show/NCT00117819

* Görseller ve İçerik tekif hakkına sahip olabilir